[go: up one dir, main page]

BR9813281A - Compostos de 4,5-diariloxazol, processos para sua preparação, composição farmacêutica contendo o mesmo, e seu uso - Google Patents

Compostos de 4,5-diariloxazol, processos para sua preparação, composição farmacêutica contendo o mesmo, e seu uso

Info

Publication number
BR9813281A
BR9813281A BR9813281-4A BR9813281A BR9813281A BR 9813281 A BR9813281 A BR 9813281A BR 9813281 A BR9813281 A BR 9813281A BR 9813281 A BR9813281 A BR 9813281A
Authority
BR
Brazil
Prior art keywords
hydrogen
preparation
pharmaceutical composition
processes
composition containing
Prior art date
Application number
BR9813281-4A
Other languages
English (en)
Inventor
Kouji Hattori
Naoaki Fujiii
Akira Tanaka
Fujiko Takamura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9813281A publication Critical patent/BR9813281A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"COMPOSTOS DE 4,5-DIARILOXAZOL, PROCESSOS PARA SUA PREPARAçãO, COMPOSIçãO FARMACêUTICA CONTENDO O MESMO, E SEU USO". Compostos da fórmula (I) onde R^ 1^ é hidrogênio ou grupo carboxi-protetor, R^ 2^, R^ 5^, R^ 6^ e R^ 7^ são, cada qual, hidrogênio ou hidroxi, R^ 3^ e R^ 4^ são, cada qual, hidrogênio ou são combinados para formar epóxi ou ligação simples, R^ 8^ e R^ 9^ são, cada qual, arila opcionalmente substituída, e X é ligação simples ou metileno, além do acima citado, R^ 2^ e R^ 3^ podem ser combinados para formar uma ligação simples; contanto que quando R^ 2^, R^ 5^, R^ 6^ e R^ 7^ forem, cada qual, hidrogênio, então R^ 3^ e R^ 4^ sejam combinados para formar epóxi; quando R^ 3^ e R^ 4^ forem combinados para formar ligação simples, então pelo menos um de R^ 2^, R^ 5^, R^ 6^ e R^ 7^ seja hidroxi e o(s) outro(s) seja(m) hidrogênio; e quando R^ 3^ e R^ 4^ forem, cada qual, hidrogênio, então pelo menos um de R^ 2^, R^ 5^, R^ 6^ e R^ 7^ seja hidroxi e o(s) outro(s) seja(m) hidrogênio e X seja metileno, ou seu sal, processo para sua preparação, uma composição farmacêutica incluindo o mesmo e seu uso.
BR9813281-4A 1997-10-27 1998-10-01 Compostos de 4,5-diariloxazol, processos para sua preparação, composição farmacêutica contendo o mesmo, e seu uso BR9813281A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP0032A AUPP003297A0 (en) 1997-10-27 1997-10-27 4,5-diaryloxazole compounds
PCT/JP1998/004455 WO1999021843A1 (en) 1997-10-27 1998-10-01 4, 5-diaryloxazole compounds

Publications (1)

Publication Number Publication Date
BR9813281A true BR9813281A (pt) 2000-08-22

Family

ID=3804308

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813281-4A BR9813281A (pt) 1997-10-27 1998-10-01 Compostos de 4,5-diariloxazol, processos para sua preparação, composição farmacêutica contendo o mesmo, e seu uso

Country Status (12)

Country Link
US (1) US6297267B1 (pt)
EP (1) EP1027340A1 (pt)
JP (1) JP2001521029A (pt)
KR (1) KR20010031204A (pt)
CN (1) CN1278252A (pt)
AR (1) AR017523A1 (pt)
AU (1) AUPP003297A0 (pt)
BR (1) BR9813281A (pt)
CA (1) CA2307952A1 (pt)
HU (1) HUP0004177A3 (pt)
TW (1) TW450966B (pt)
WO (1) WO1999021843A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP608898A0 (en) * 1998-09-23 1998-10-15 Fujisawa Pharmaceutical Co., Ltd. New use of prostaglandin E2 antagonists
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
AUPQ253199A0 (en) 1999-08-30 1999-09-23 Fujisawa Pharmaceutical Co., Ltd. Non-prostanoid prostaglandin I2-agonist
TWI316055B (pt) * 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
KR101587071B1 (ko) 2008-07-23 2016-01-20 도레이 카부시키가이샤 만성 신부전 처치제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344836A (en) * 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
US5362879A (en) * 1993-04-15 1994-11-08 Bristol-Myers Squibb Company 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
KR100345943B1 (ko) * 1993-12-20 2002-11-30 후지사와 야꾸힝 고교 가부시키가이샤 4,5-디아릴옥사졸유도체
ES2160156T3 (es) 1994-03-10 2001-11-01 Fujisawa Pharmaceutical Co Derivados de naftaleno como agonistas de la prostaglandina i2.
TW401408B (en) * 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism

Also Published As

Publication number Publication date
AR017523A1 (es) 2001-09-12
AUPP003297A0 (en) 1997-11-20
HUP0004177A3 (en) 2002-10-28
WO1999021843A1 (en) 1999-05-06
US6297267B1 (en) 2001-10-02
JP2001521029A (ja) 2001-11-06
CN1278252A (zh) 2000-12-27
KR20010031204A (ko) 2001-04-16
TW450966B (en) 2001-08-21
HUP0004177A2 (hu) 2001-05-28
CA2307952A1 (en) 1999-05-06
EP1027340A1 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
IL90912A0 (en) Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
SE8502573D0 (sv) Fluorescent lanthanide chelates useful as labels of physiologically active materials
FI941987L (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset
BR9911771A (pt) Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
DE69016667D1 (de) Stabilisierte komplexe bestehend aus stickoxyd/primäre amine zur verwendung als kardiovaskuläre wirkstoffe.
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
AU560436B2 (en) 5-substituted 1,2,4,-oxadiazole derivatives
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
DE69429570D1 (de) Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
PT83535B (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos
DE69735845D1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
DE68912160D1 (de) Verfahren zur Herstellung von beta-Lactamderivaten.
DK0714387T3 (da) Hidtil ukendte bis-naphthalimider til behandling af cancer
BR9713159A (pt) Composição substancialmente sólida, composto, composição de sal substancialmente sólida, mistura, e, processo para preparar um composto
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
BR9813281A (pt) Compostos de 4,5-diariloxazol, processos para sua preparação, composição farmacêutica contendo o mesmo, e seu uso
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
ATE220393T1 (de) Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
BG94474A (bg) Метод за разделяне на органични вещества
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
PT90127A (pt) Processo para a preparacao de composicoes farmaceuticas com accao analgesica que contem 4-aril-4-piperidino (ou pirrolidino ou hexa-hidroazepino)-carbinois ou os seus analogos heterociclicos
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007.